Evidence Hub

A Rare Case of Stevens-Johnson Syndrome Secondary to Levofloxacin Administration: Presentation and Management

Chrysostomou M, Shah N, Ravikumar A, Khan F

Cureus, 2026

1 citation

Abstract

Stevens-Johnson syndrome (SJS) is a rare but life-threatening mucocutaneous reaction, most commonly triggered by medications and characterised by rapid progression, extensive mucosal involvement, and risk of long-term sequelae. We describe the case of a 74-year-old woman who developed severe SJS shortly after receiving levofloxacin for community-acquired pneumonia. Within days of antibiotic exposure, she experienced extensive mucocutaneous ulceration and profound ocular involvement, necessitating intensive multidisciplinary care. This case highlights the unpredictable nature of drug-associated SJS, the challenges of managing extensive ocular disease, and the importance of vigilance when prescribing widely used antibiotics. By underscoring the value of early identification and coordinated multidisciplinary care, it serves as a reminder that even familiar medications can provoke uncommon but severe reactions with the potential to cause life-changing consequences.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free